Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4541185012 | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4541186013 | Epidermal growth factor receptor antagonist antineoplastic agent | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Epidermal growth factor receptor antagonist antineoplastic agent | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Epidermal growth factor receptor antagonist antineoplastic agent | Is a | Enzyme inhibitor-containing product | false | Inferred relationship | Some | ||
| Epidermal growth factor receptor antagonist antineoplastic agent | Is a | Protein kinase inhibitor-containing product | true | Inferred relationship | Some | ||
| Epidermal growth factor receptor antagonist antineoplastic agent | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Epidermal growth factor receptor antagonist antineoplastic agent | Has active ingredient | Epidermal growth factor receptor antagonist | true | Inferred relationship | Some | 1 | |
| Epidermal growth factor receptor antagonist antineoplastic agent | Is a | Medicinal product categorised by disposition | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Osimertinib-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Necitumumab-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Gefitinib-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Erlotinib-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Vandetanib-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Lapatinib-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Trastuzumab deruxtecan-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Trastuzumab-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Pertuzumab-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Trastuzumab emtansine-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Margetuximab-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Amivantamab-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Cetuximab-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Protein-tyrosine kinase inhibitor-containing product | Is a | False | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some | |
| Panitumumab-containing product | Is a | True | Epidermal growth factor receptor antagonist antineoplastic agent | Inferred relationship | Some |
This concept is not in any reference sets
FHIR